| Revenue growth | 22% YoY in Q1 FY27 |
|---|---|
| Margins | EBITDA margin 25% (down from 27%) |
| Order book | 200+ CT/MRI centers on order-book completion |
| Demand visibility | Strong, 76Mn+ patients served in 5 years |
| Management confidence | High on retail and PPP synergy |
Growth
Revenue grew 22% YoY to ₹2,355 Mn; EBITDA rose 12% to ₹588 Mn; PAT declined 19% to ₹166 Mn.
Outlook
Focus on cash business, scaling Rajasthan labs, and achieving 200+ CT/MRI centers on order-book completion.
Risks
Margin moderation (EBITDA margin -221 bps) due to upfront fixed costs in Rajasthan and Tamil Nadu MRI discontinuation.
Last quarter's promises, checked
Delivered
- Guided Rajasthan contribution in Q1 FY27 → delivered 22% overall revenue growth (= BEAT)
- Guided 200+ CT/MRI centers on order-book completion → delivered 190+ currently operational (= BEAT)
- Guided retail contribution to scale up → delivered 64% YoY retail revenue growth (= BEAT)
Partly delivered
- Guided reducing DSO to sub-120 days → delivered 139 days (= PARTIAL)
Missed
- Guided maintaining EBITDA margins at 28-30% → delivered 25% (= MISS)
Investor Presentation filed with BSE, NSE: KRSNAA. Summary written with AI assistance from the document.
Krsnaa Diagnostics Ltd: key numbers
- Share price
- ₹548.45
- Market cap
- ₹1,779 Cr
- Revenue (annual)
- ₹772.8 Cr
- Net profit (annual)
- ₹101.4 Cr
- P/E (TTM)
- 18.2×Sector 57.8×
- Promoter holding
- 27.11%+0.00% QoQ
- FII holding
- 4.28%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Krsnaa Diagnostics Ltd
All →Krsnaa Diagnostics Annual General Meeting
Krsnaa Diagnostics Ltd reported the successful passing of a special resolution via postal ballot approving the issuance of up to 16,21,000 convertible warrants to promoters.
Krsnaa Diagnostics Bags New Order from Department of Health & Family Welfare, Government of Punjab
Krsnaa Diagnostics executed a 15-year concession agreement with the Punjab Government to develop and operate PET-CT diagnostic facilities at four government hospitals.
- From
- Department of Health & Family Welfare, Government of Punjab
- Execution
- 15 years
- diagnostic facilities
- 4.0 hospitals
Krsnaa Diagnostics Legal & Regulatory
Krsnaa Diagnostics received tax appellate orders for AY 2017-24 with aggregate disputed demands of ₹62.69 Crore. The company plans to file further appeals.
- Value
- ₹62.69 Cr
Krsnaa Diagnostics Other Announcement
Krsnaa Diagnostics has filed its Business Responsibility and Sustainability Report for the financial year 2025-26 as required by regulatory listing obligations.
Krsnaa Diagnostics Annual General Meeting
Krsnaa Diagnostics Limited has submitted the notice of its 16th Annual General Meeting, scheduled for September 28, 2026, along with the Annual Report for 2025-26.
Krsnaa Diagnostics Earnings Call Transcript: Key Takeaways
Krsnaa reported 22% revenue growth but suffered margin compression due to heavy front-ended costs for the Rajasthan project. Management pivots to 'long-term value' to deflect from current EBITDA and PAT dips.
- Call
- Guides 100% growth